•
Sep 30, 2023

Inhibrx Biosciences Inc Q3 2023 Earnings Report

Total Revenue
$119K
Previous year: $278K
-57.2%
EPS
-$1.1
Previous year: -$0.9
+22.2%
Gross Profit
-$185K
Cash and Equivalents
$337M
Free Cash Flow
-$55.1M

Inhibrx Biosciences Inc

Inhibrx Biosciences Inc